{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:26:20Z","timestamp":1781702780916,"version":"3.54.5"},"reference-count":60,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"unspecified","delay-in-days":123,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2021,8,3]]},"DOI":"10.1080\/21645515.2021.1880209","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T22:26:37Z","timestamp":1614291997000},"page":"2777-2787","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4437-4093","authenticated-orcid":false,"given":"Sara Viksmoen","family":"Watle","sequence":"first","affiliation":[{"name":"Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbeth Meyer","family":"N\u00e6ss","sequence":"additional","affiliation":[{"name":"Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gro","family":"Tunheim","sequence":"additional","affiliation":[{"name":"Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique A.","family":"Caugant","sequence":"additional","affiliation":[{"name":"Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f8rn","family":"Wisl\u00f8ff","sequence":"additional","affiliation":[{"name":"Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"Department of Community Medicine, Institute of Community Medicine, UiT the Arctic University of Norway, Troms\u00f8, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.020"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0213-2"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-019-0282-6"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2016.04.012"},{"key":"e_1_3_4_6_1","unstructured":"European Centre for Disease Prevention and Control. Invasive meningococcal disease. In: ECDC. Annual epidemiological report for 2017. Stockholm: ECDC; 2019 [accessed 2019 Oct 16]. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/AER_for_2017-invasive-meningococcal-disease.pdf."},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-019-01129-z"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00261"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.16.18-00158"},{"key":"e_1_3_4_10_1","unstructured":"Public Health England. Meningococcal ACWY immunisation programme for adolescents information for healthcare professionals. London (UK): Crown; 2020 [accessed 2020 Oct 16]. https:\/\/www.gov.uk\/government\/publications\/menacwy-programme-information-for-healthcare-professionals."},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46483-3"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-017-0587-4"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1086\/599117"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182054ab9"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(11)61713-3"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614474"},{"key":"e_1_3_4_17_1","unstructured":"European Centre for Disease Prevention and Control. Vaccine schedules in all countries of the European Union. [accessed 2019 Oct 15]. https:\/\/vaccine-schedule.ecdc.europa.eu\/."},{"key":"e_1_3_4_18_1","unstructured":"Norwegian Institute of Public Health. Norwegian surveillance system for communicable diseases. Oslo (Norway): Norwegian Institute of Public Health; [accessed 2019 Dec 16]. http:\/\/msis.no\/."},{"key":"e_1_3_4_19_1","unstructured":"Taylor K. Norwegian teens celebrate a bizarre month-long holiday full of drinking sex and wild dares \u2014 here\u2019s what it\u2019s like. Business Insider. 2018 Apr 18 [cited 2019 Dec 16]. https:\/\/www.businessinsider.com\/what-the-norwegian-teen-holiday-russefeiring-is-like-2017-6?r=US&IR=T."},{"key":"e_1_3_4_20_1","unstructured":"Norwegian Immunisation Registry SYSVAK. Oslo (Norway): Norwegian Institute of Public Health; 2019 [accessed 2019 Apr 10]. https:\/\/www.fhi.no\/en\/hn\/health-registries\/norwegian-immunisation-registry-sysvak\/."},{"key":"e_1_3_4_21_1","unstructured":"Alarid-Escudero F Krijkamp EM Enns EA Myriam Hunink MG Pechlivanoglou P Jalal H. Cohort state-transition models in R: a tutorial. arXiv:200107824. 2020 Jan 22 [cited 2020 Feb 24]. https:\/\/ui.adsabs.harvard.edu\/abs\/2020arXiv200107824A."},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989x19893973"},{"key":"e_1_3_4_23_1","unstructured":"Norwegian Ministry of Finance. Oslo (Norway); [accessed 2019 Oct 9]. https:\/\/www.regjeringen.no\/en\/dep\/fin\/id216\/"},{"key":"e_1_3_4_24_1","unstructured":"Norwegian Medicines Agency. Guidelines for the submission of documentation for single technology assessment (STA) of pharmaceuticals. Oslo (Norway): Norwegian Medicines Agency; 2018 [accessed 2019 Oct 10]. https:\/\/legemiddelverket.no\/Documents\/English\/Public%20funding%20and%20pricing\/Documentation%20for%20STA\/Guidelines_april_2018.pdf."},{"key":"e_1_3_4_25_1","unstructured":"Norheim O Allgott B Gjul G Kjellevold A Moen A Sj\u00f8li S Aschim B Gundersen T Kvinnsland S \u00d8 M et al. Norwegian [Transparent and fair \u2013 priorities in health services]. Oslo (Norway): Norwegian Government; 2014. https:\/\/www.regjeringen.no\/no\/dokumenter\/NOU-2014-12\/id2076730\/?ch=1."},{"key":"e_1_3_4_26_1","unstructured":"Statistics Norway. Oslo (Norway); [accessed 2019 Oct 9]. https:\/\/www.ssb.no\/en\/."},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e318279ac38"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0000000000000866"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(14)60842-4"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1454570"},{"key":"e_1_3_4_31_1","unstructured":"Norwegian: [Statistics for childhood vaccination]. Oslo (Norway): Norwegian Institute of Public Health; 2018 [accessed 2019 Oct 14]. https:\/\/www.fhi.no\/hn\/helseregistre-og-registre\/sysvak\/barnevaksinasjon\u2014statistikk\/."},{"key":"e_1_3_4_32_1","unstructured":"EQ-5D (EuroQo 5 dimensions). Rotterdam (The Netherlands): EuroQol Group; 2020 [accessed 2019 Oct 9]. https:\/\/euroqol.org\/."},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494811435493"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1023\/a:1013171831202"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2009.01.040"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ506"},{"key":"e_1_3_4_37_1","unstructured":"Exchange rates. Oslo (Norway): Norges Bank; 2018 [accessed 2019 Oct]. https:\/\/www.norges-bank.no\/en\/topics\/Statistics\/exchange_rates\/."},{"key":"e_1_3_4_38_1","unstructured":"Norwegian Medicines Agency. Oslo (Norway); [accessed 2019 Oct 14]. https:\/\/legemiddelverket.no\/english."},{"key":"e_1_3_4_39_1","unstructured":"Norwegian: [ISF_regulations_2018 \u2013 DRGlist somatic]. Norwegian Directorate of Health; 2018 [accessed 2019 Oct 14]. https:\/\/www.helsedirektoratet.no\/tema\/finansiering\/innsatsstyrt-finansiering-og-drg-systemet\/innsatsstyrt-finansiering-isf\/ISF_Regelverk_2018%20%E2%80%93%20DRGliste%20Somatikk%20(Vedlegg%20A1).xlsx?download=true."},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0000000000001512"},{"key":"e_1_3_4_41_1","unstructured":"Summary of Product Characteristics \u2013 Nimenrix. European Medicines Agency; [accessed 2019 Oct 28]. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/nimenrix-epar-product-information_en.pdf."},{"key":"e_1_3_4_42_1","unstructured":"Summary of Product Characteristics \u2013 Menveo. European Medicines Agency; [accessed 2019 Oct 28]. https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/menveo-epar-product-information_en.pdf."},{"key":"e_1_3_4_43_1","unstructured":"Norwegian Ministry of Health and Care Services. Principles for priority setting in health care - Summary of a white paper on priority setting in the norwegian health care sector. Oslo (Norway): Norwegian Government; 2016. https:\/\/www.regjeringen.no\/contentassets\/439a420e01914a18b21f351143ccc6af\/en-gb\/pdfs\/stm201520160034000engpdfs.pdf."},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.02.017"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989x13505910"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1017\/s0950268820000734"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065036"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.07.008"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1086\/524041"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2514"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175721"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.04.071"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2016.1130628"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2015.1084232"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.09.48"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-017-0606-1"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2016.03.041"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.3259"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.985"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.11.015"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-2193"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2021.1880209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T14:54:30Z","timestamp":1709304870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2021.1880209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,3]]}},"alternative-id":["10.1080\/21645515.2021.1880209"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2021.1880209","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-10-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}